Clinical-epidemiological profile and factors associated with viral non-suppression in patients living with HIV/AIDS assisted at the Integrated Treatment Center at the Maputo Military Hospital (CITRA/MMH), 2019 to 2020

Author:

Chicanequisso Eduardo Mangue,Baltazar Cynthia Sema,Sacarlal Jahit

Abstract

Abstract Background HIV remains a critical global public health challenge. In 2022, it was estimated that approximately 39.0 million people worldwide were living with HIV, and of these, around 29.8 million were receiving antiretroviral therapy (ART). The objective was to evaluate the clinical and epidemiological profile and factors associated with viral load (VL) non-suppression in people living with HIV/AIDS at the Maputo Military Hospital (CITRA/MMH). Methods A retrospective cross-sectional analytical study was conducted on 9105 people aged 15 years and over. We use secondary data from participants on ART for at least 2 years being followed up between the years 2019–2020 at CITRA/MMH. Those recently enrolled (on ART < 1 year) were excluded and data analysis was performed using STATA version 16. Pearson's chi-square test and logistic regression were used for statistical modeling of viral non-suppression with a 95%/CI confidence interval and p < 0.05. Results Among a total of 9105 HIV participants included, 52.8% (n = 4808) were female and 13.6% (n = 1235) were military personnel. The average age was 47.9 years (standard deviation ± 12.1), with the most prevalent age group being individuals aged between 25 and 59, totalizing 7,297 (80.2%) participants. Only 5395 (100%) participants had VL results. Among these, 23.1% (n = 1247) had a result VL non-suppressed. Single marital status (Adjusted Odds Ratio [AOR] = 4.8, 95%CI: 3.93–5.76, p < 0.001), with active tuberculosis (AOR = 4.6, 95%CI: 3.15–6.63, p < 0.001) and current ART regimen in categories TDF + 3TC + EFV (AOR = 12.7, 95%CI: 9.74–16.63, p < 0.001), AZT + 3TC + NVP (AOR = 21.8, 95% CI: 14.13–33.59, p < 0.001) and “other” regimens (AOR = 25.8, 95%CI: 18.58–35.80, p < 0.001), when compared to the TDF + 3TC + DTG regime, were statistically significant for viral non- suppression. Conclusion The study highlights the crucial role of ART adherence and ongoing monitoring to achieve viral suppression, particularly among adults aged 25 to 59. It underscores the need for transitioning eligible individuals to DTG-based regimens and addressing the implications of single marital status and comorbid conditions like active tuberculosis. The study emphasizes the importance of ARV adherence and continuous monitoring to meet the UNAIDS 95–95-95 targets and improve clinical outcomes for people living with HIV/AIDS.

Publisher

Springer Science and Business Media LLC

Reference30 articles.

1. UNAIDS Mozambique. Country factsheets: Mozambique. 2023. https://www.unaids.org/en/regionscountries/countries/mozambique. Accessed 29 August 2023.

2. UNAIDS. Global HIV & AIDS statistics — Fact sheet. 2023. https://www.unaids.org/en/resources/fact-sheet. Accessed 29 August 2023.

3. INS. Resultados do Inquérito sobre o Impacto do HIV e SIDA em Moçambique. Instituto Nacional de Saúde. 2022. https://ins.gov.mz/divulgados-resultados-do-inquerito-sobre-o-impacto-do-hiv-e-sida-em-mocambique/. Accessed 14 March 2023.

4. United States Government. Department of Defense HIV/AIDS Prevention Program. 2020. https://tg.usembassy.gov/wp-content/uploads/sites/220/DHAPP_RAA-PA_2020_Jan-7-2020-Revision.pdf. Accessed 23 May 2021.

5. Endres-Dighe S, Farris T, Courtney L. Lessons learned from twelve years of HIV Seroprevalence and Behavioral Epidemiology Risk Survey (SABERS) development and implementation among foreign militaries. PLoS ONE. 2018;13(9). https://doi.org/10.1371/journal.pone.0203718.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3